Role of data, analytics and insights in health care
doubling every two years by some estimates.
doubling every two years by some estimates.
I was asked to share with Chain Drug Review readers a few thoughts about what is new in terms of pharmacy and front-end topics. As it turns out, the answer to this question is very similar to the answer to another frequently asked question: What will be new at the 2016 NACDS Total Store Expo?
It has been slightly more than nine months since Walgreens Boots Alliance agreed to acquire Rite Aid in a $17.2 billion all-cash transaction.
In today’s retail and consumer packaged goods marketplace, consumer shopping habits are changing rapidly. Households have more choices in where and how they shop, what they buy, and how they engage with retailers and brands while making their purchase decisions.
and the news concerning the chain drug store community has hardly made a ripple. The Walgreens acquisition of Rite Aid remains a work in progress, though all parties hoped it would have been completed by now. The NACDS Total Store Expo event is unfolding without many
The continuous roller coaster of retail sales results could make even the greatest optimist weep. In recent months, when retailers like Macy’s, Nordstrom, Kohl’s, J.C. Penney and Target reported less than stellar results, it was hard not to take on a Chicken Little view that the sky was falling.
The Environmental Protection Agency (EPA) recently proposed steps to streamline the process surrounding the disposal and handling of hazardous pharmaceutical waste for all health care facilities that dispense pharmaceuticals as set forth by the Resource Conservation and Recovery Act (RCRA).
When my children were younger, reminders about vaccinations were inescapable. Notifications come by way of regular pediatrician visits, health forms to be completed to enroll in school, and checklists on every Boy Scout camp or sports-participation medical form.
including mergers and acquisitions, downward pressure on reimbursement rates, consolidation of payers, and a nascent movement to transform pharmacists into providers — now is a good time to take a step back and look at the big picture. What forces will transform the industry, and which
On February 1, 2016, the Centers for Medicare & Medicaid Services (CMS) released its Final Rule interpreting the provisions of the 2010 health care reform law that address the Medicaid Drug Rebate Program (MDRP).
The second annual Amazon Prime Day was held this month and, despite early technical problems that slowed down the checkout process for some customers, it was another in a series of successes for the nation’s leading online merchant. The company reported that the event was the best day in Amazon.
Chain drug store operators are unique among mass market retailers in many ways, none more dramatic than the separation of the pharmacy and front-end businesses. In fact, they are actually two separate businesses, neither overly dependent on the other for success.
CHAPTER 8: TOWARD A NEW MODEL OF COLLABORATION AND COMPETITION All new healthcare business and operating models must rapidly embrace technologies that are fundamentally collaborative; building ecosystems of value-enabling partnerships is both strategic and an operating imperative.
Recent studies point to digital as the primary force driving the business and societal changes that are affecting company operations across industries. Because retail and health care are facing the most disruption, North American pharmacies can no longer afford to watch from the sidelines.